Hasil Pencarian - Maksim S. Eliseev

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Canakinumab (an interleukin 1β inhibitor) is a breakthrough in the possibilities of anti-inflammatory therapy for gout

    Canakinumab (an interleukin 1β inhibitor) is a breakthrough in the possibilities of anti-inflammatory therapy for gout oleh Maksim Sergeevich Eliseev, V G Barskova, E L Nasonov

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Use of meloxicam (amelotex®) in patients with gonarthrosis

    Use of meloxicam (amelotex®) in patients with gonarthrosis oleh Maksim Sergeevich Eliseev, S A Vladimirov, Maksim Sergeyevich Eliseyev, S A Vladimirov

    Diterbitkan 2011-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy

    Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy oleh Maksim Sergeevich Eliseev, S A Vladimirov, Maksim Sergeyevich Eliseyev, S A Vladimirov

    Diterbitkan 2011-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy

    Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy oleh Maksim Sergeevich Eliseev, S A Vladimirov, Maksim Sergeyevich Eliseyev, S A Vladimirov

    Diterbitkan 2011-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Use of meloxicam (amelotex®) in patients with gonarthrosis

    Use of meloxicam (amelotex®) in patients with gonarthrosis oleh Maksim Sergeevich Eliseev, S A Vladimirov, Maksim Sergeyevich Eliseyev, S A Vladimirov

    Diterbitkan 2011-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Advantages of the use of metformin in patients with impaired uric acid metabolism

    Advantages of the use of metformin in patients with impaired uric acid metabolism oleh Maksim S. Eliseev, Taras S. Panevin, Olga V. Zhelyabina, Evgeny L. Nasonov

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS

    Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS oleh Maksim Sergeevich Eliseev, Viktoriya Georgievna Barskova, M S Eliseev, V G Barskova

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT

    EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT oleh Maksim Sergeyevna Eliseev, O V Zhelyabin, V G Barskova, E L Nasonov

    Diterbitkan 2014-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Main factors of gender dimorphism of gout (estrogens and diuretics vs alcohol and genetics)

    Main factors of gender dimorphism of gout (estrogens and diuretics vs alcohol and genetics) oleh Viktoriya Georgievna Barskova, Maksim Sergeevich Eliseev, Nailya Alekperovna Chikalenkova, V G Barskova, M S Eliseev, N A Chikalenkova

    Diterbitkan 2011-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    ATYPICAL GOUT: SPINAL TOPHACEOUS INJURY

    ATYPICAL GOUT: SPINAL TOPHACEOUS INJURY oleh Maksim Sergeevich Eliseev, M V Mukagova, A V Smirnov, S G Radenska-Lopovok, L A Bozhyeva, V G Barskova

    Diterbitkan 2013-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: